Free Trial

CervoMed (CRVO) Earnings Date, Estimates & Call Transcripts

CervoMed logo
$8.74 -0.04 (-0.42%)
As of 01:27 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CervoMed Earnings Summary

CervoMed announced Q1 2025 earnings on May 12, 2025, reporting an EPS of -$0.56, which beat analysts' consensus estimates of -$0.60 by $0.04. Quarterly revenue was reported to be $1.92 million, above the consensus estimate of $1.70 million. With a trailing EPS of -$2.18, CervoMed's earnings are expected to grow next year, from ($1.88) to ($1.69) per share.

Upcoming Q2
Earnings Date
Aug. 8Before Market OpensEstimated
Consensus EPS
(May. 12)
-$0.60
Actual EPS
(May. 12)
-$0.56 Beat By $0.04
Actual Revenue
(May. 12)
$1.92M

Q1 2025 Earnings Resources

CRVO Upcoming Earnings

CervoMed's next earnings date is estimated for Friday, August 8, 2025, based on past reporting schedules.

Get CervoMed Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CervoMed and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CRVO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CRVO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

CervoMed Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20253-$0.80-$0.47-$0.60
Q2 20253-$0.75-$0.39-$0.55
Q3 20253-$0.50-$0.34-$0.42
Q4 20253-$0.61-$0.32-$0.46
FY 2025 12 -$2.66 -$1.52 -$2.03
Q1 20261-$0.52-$0.52-$0.52
Q2 20261-$0.61-$0.61-$0.61
Q3 20261-$0.75-$0.75-$0.75
Q4 20261-$0.91-$0.91-$0.91

CervoMed Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/8/2025
(Estimated)
--------
5/12/2025Q1 2025-$0.60-$0.56+$0.04-$0.56$1.70M$1.92M
3/17/2025Q4 2024-$0.67-$0.80 -$0.13-$0.80$1.51M$2.16M
11/12/2024--$0.41-$0.55 -$0.14-$0.55$1.75M$1.94M
8/12/2024--$0.24-$0.27 -$0.03-$0.27$3.48M$3.29M
5/14/2024Q1 2024-$0.46-$0.41+$0.05-$0.41$2.00M$2.35M
11/13/2023Q3 2023-$0.95-$0.70+$0.25-$0.70-$1.53M
8/8/2023Q2 2023--$1.56 -$1.56-$1.56--

CervoMed Earnings - Frequently Asked Questions

CervoMed has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 8th, 2025 based off last year's report dates. Learn more on CRVO's earnings history.

In the previous quarter, CervoMed (NASDAQ:CRVO) reported ($0.56) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.60) by $0.04. Learn more on analysts' earnings estimate vs. CRVO's actual earnings.

CervoMed (NASDAQ:CRVO) has a recorded annual revenue of $7.14 million.

CervoMed (NASDAQ:CRVO) has a recorded net income of -$2.17 million. CRVO has generated -$2.18 earnings per share over the last four quarters.

CervoMed's earnings are expected to grow from ($1.88) per share to ($1.69) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:CRVO) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners